Skip to content
naulon
Not checkedNot checked for notices yet.

Mucosal delivery of anti-inflammatory IL-1Ra by sporulating recombinant bacteria

Ruggiero Paolo, Bossù Paola, Porzio Stefano and 2 more

BMC Biotechnology · 2004

doi:10.1186/1472-6750-4-27 (opens in a new tab)

We email you when a new notice or a question about this paper appears.

Abstract

<p>Abstract</p> <p>Background</p> <p>Mucosal delivery of therapeutic protein drugs or vaccines is actively investigated, in order to improve bioavailability and avoid side effects associated with systemic administration. Orally administered bacteria, engineered to produce anti-inflammatory cytokines (IL-10, IL-1Ra), have shown localised ameliorating effects in inflammatory gastro-intestinal conditions. However, the possible systemic effects of mucosally delivered recombinant bacteria have not been investigated.</p> <p>Results</p> <p><it>B. subtilis </it>was engineered to produce the mature human IL-1 receptor antagonist (IL-1Ra). When recombinant <it>B. subtilis </it>was instilled in the distal colon of rats or rabbits, human IL-1Ra was found both in the intestinal lavage and in the serum of treated animals. The IL-1Ra protein in serum was intact and biologically active. IL-1-induced fever, neutrophilia, hypoglycemia and hypoferremia were inhibited in a dose-dependent fashion by intra-colon administration of IL-1Ra-producing <it>B. subtilis</it>. In the mouse, intra-peritoneal treatment with recombinant <it>B. subtilis </it>could inhibit endotoxin-induced shock and death. Instillation in the rabbit colon of another recombinant <it>B. subtilis </it>strain, which releases bioactive human recombinant IL-1β upon autolysis, could induce fever and eventually death, similarly to parenteral administration of high doses of IL-1β.</p> <p>Conclusions</p> <p>A novel system of controlled release of pharmacologically active proteins is described, which exploits bacterial autolysis in a non-permissive environment. Mucosal administration of recombinant <it>B. subtilis </it>causes the release of cytoplasmic recombinant proteins, which can then be found in serum and exert their biological activity <it>in vivo </it>systemically.</p>

Abstract licence: CC BY-NC-ND

Reads

Read by people on this page

None yet.

Checked or read by AI through naulon

None yet.

A person counts once a day per paper. We keep no cookie and no address: a reader is a hash that changes every day. Any month under five reads shows no number.

Are you an author?

Is this your paper?

Claim it to add your note and be paid when agents cite it. Free.